Cite
HARVARD Citation
Zundelevich, A. et al. (n.d.). 17P Using ex vivo organ culture technology to evaluate a T cell bispecific (TCB) CEACAM5 therapy. Immuno-oncology technology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zundelevich, A. et al. (n.d.). 17P Using ex vivo organ culture technology to evaluate a T cell bispecific (TCB) CEACAM5 therapy. Immuno-oncology technology. p. . [Online].